Data Characteristics for This Category
Phase II-III clinical product data primarily originates from clinical trial protocols, Investigator's Brochures (IB), Informed Consent Forms (ICF), Clinical Study Reports (CSR), ethics review documents, and regulatory submission materials. These documents typically exist as PDFs, Word files, or structured data (e.g., CSV, XML). Data update frequency is relatively low, mainly occurring when submitting different stage-specific reports of a clinical trial. Document structures are complex, containing extensive specialized terminology, dosage units (e.g., mg/kg, IU), statistical data, and charts. Documents are lengthy and feature numerous cross-references. Fields include subject information, drug dosage, adverse events (AEs), laboratory test results, efficacy evaluation indicators, etc. Units are highly standardized, but expressions vary.
Constraints Imposed by These Characteristics on "Vector Model and Indexing"
The complexity and specialized nature of Phase II-III clinical data impose specific requirements on vector models and indexing. Long documents and cross-references necessitate support for long-text chunking and context association to avoid losing critical information. The presence of specialized terminology and standardized units requires vector models to have a good understanding of domain-specific vocabulary to ensure accurate semantic similarity calculations. Low update frequency makes batch indexing the primary approach, but each update requires efficient and consistent incremental indexing. While current vector models struggle to directly index chart information within documents, the surrounding text descriptions are often crucial and require attention during chunking. Precise recall of critical information like adverse events demands higher similarity thresholds and more refined reranking strategies.
Configuration Guidelines
| Configuration Item | Recommended Value | Rationale for Recommendation |
|---|---|---|
Chunk size (Chunk Length) | 800–1200 characters (characters) | Balances contextual completeness with vector model processing capabilities, suitable for lengthy chapters. |
Recall count (Recall Count) | Top 10–15 entries (top 10–15 items) | Ensures coverage of potentially relevant information, addressing complex queries and multi-source data. |
Similarity threshold (Similarity Threshold) | Calibrate by actual measurement (calibrate by actual measurement) | Requires iterative testing for specific medical terminology and data, aiming for high-precision recall. |
Rerank result count (Rerank Return Count) | Top 3–5 entries (top 3–5 items) | Focuses on the most relevant content, reducing the processing burden on downstream models. |
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds (seconds) | Accommodates parsing time for large PDF/Word documents. |
maxContext | 4096 tokens | Adapts to long-context queries, ensuring clinical details are not truncated. |
Three Common Pitfalls
- During online recall testing after knowledge base indexing, irrelevant or missing results indicate an improper chunking strategy. This leads to critical information being truncated or insufficient context.
- Embedding model connection errors to external OneAPI typically stem from incorrect API Key configuration or network connectivity issues, preventing normal invocation of the Embedding service.
- When a Rerank model is configured, but online testing shows an insignificant reranking effect (e.g., returned item order does not match expectations), the rerank model might not be loaded correctly or its parameters are unsuitable for the current data characteristics.
Confirmation of Proper Configuration
- For core query statements, perform online recall tests. Check if the
relevance scoreof the returned document snippets is within the expected range and manually assess content accuracy. - Upload a typical Phase II-III clinical trial report (e.g., a CSR containing an adverse event list). Observe if the indexing process completes successfully and check
parsing logsfor errors. - Use queries containing specific specialized terminology and dosage units. Verify if the recall results include these key pieces of information and optimize recall precision by adjusting the
Similarity threshold(similarity threshold).
Note: The values provided are common starting points. Measure against your own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.